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Several transcription factors (TFs) play crucial roles in governing the expression of different
genes involved in the immune response, embryo or cell lineage development, cell apoptosis, cell
cycle progression, oncogenesis, repair and fibrosis processes and inflammation. As far as
inflammation, TFs playing pivotal roles are nuclear factor kappa B (NF-kB), activator protein
(AP-1), signal transducer and activator of transcription (STATs), cAMP response element
binding protein (CREB) and GATA-1 factors. All these TFs regulate the expression of pro-
inflammatory cytokines and are involved in the pathogenesis of a number of human disorders,
particularly those with an inflammatory component. Since several medicinal plants can be
employed to produce extracts exhibiting biological effects and because alteration of gene
transcription represents a very interesting approach to control the expression of selected genes,
this study sought to verify the ability of several extracts derived from Bangladeshi medicinal
plants in interfering with molecular interactions between different TFs and specific DNA
sequences. We first analyzed the antiproliferative activity of 19 medicinal plants on different
human cell lines, including erythroleukemia K562, B lymphoid Raji and T lymphoid Jurkat cell
lines. Secondly, we employed the electrophoretic mobility shift assay as a suitable technique for
a fast screening of plant extracts altering the binding between NF-kB, AP-1, GATA-1, STAT-3,
CREB and the relative target DNA elements.
Keywords: AP-1 – CREB – GATA-1 – gene expression – medicinal plants – NF-kB – STAT-3 –
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Introduction
Transcription factors (TFs) play key roles in the
regulation of gene expression (1). Accordingly targeting
of TFs with DNA-based molecules (2,3) or low-molecular
weight compounds (4,5) might be of great interest to
develop selective molecules exhibiting therapeutic potential
in several human pathologies (6–8). One of the best
examples of the interplay between TFs, gene expression,
drug design and discovery and novel therapeutic
approaches is inflammation. Several TFs are indeed
involved in inflammatory processes, including Nuclear
Factor-kappa B (NF-kB) (9–14), activator protein 1 (AP-1)
(15–17), signal transducer and activator of transcription
(STATs) (18), cAMP response element binding
protein (CREB) (19) and GATA-1 factors (20,21).
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properly cited.All these TFs have been described to play a significant
role in regulating expression of genes coding pro-
inflammatory cytokines and in the pathogenesis of
a large number of human disorders, particularly
those characterized by a chronic inflammatory component
(17). These include rheumatoid arthritis (22,23),
chronic asthma (24,25), diabetes mellitus type 1 (26) and
Crohn’s disease (27).
With respect to anti-inflammatory activities, several
plant-derived compounds exhibit significant effects
(28–33). Therefore, medicinal plants represent a potential
source of molecules of significant relevance for develop-
ing novel drugs, especially designed for treating and/or
controlling chronic inflammatory conditions. Despite the
therapeutic effects of medicinal plant extracts that are
well-known and reviewed in several articles (34–44),
sparse information is available on their effects on activity
of TFs (45,46).
The main concern here was to screen Bangladeshi
medicinal plants for their activity in inhibiting the
interactions between nuclear factors and double stranded
target oligonucleotides mimicking the NF-kB, AP-1,
STAT-3, CREB and GATA-1 binding sites. To this
aim, electrophoretic mobility shift assay (47) has been
employed. Extracts from several medicinal plants have
been considered, including Emblica officinalis, Aegle
marmelos, Moringa oleifera, Terminalia arjuna, Vernonia
anthelmintica, Oroxylum indicum, Saraca asoka, Rumex
maritimus, Lagerstroemia speciosa, Red sandal, Cuscuta
reflexa, Argemone mexicana, Hemidesmus indicus,
Polyalthia longifolia, Cassia sophera, Paederia foetida,
Hygrophilla auriculata, Ocimum sanctum and Aphanamixis
polystachya.
Methods
Plant Materials and Extraction
The following plant material was extracted with absolute
ethanol in cold extraction process: (i) the stem bark of
C. sophera (yield¼10.22%), T. arjuna (yield¼10.1%),
O. indicum (yield¼11.0%), A. marmelos (yield¼12.25%),
S. asoka (yield¼14.16%), Red Sandal (yield¼13.2%), the
dried leaves of O. sanctum (yield¼3.22%), the dried whole
plant of C. reflexa (yield¼15.03%) and P. foetida Linn.
(yield¼11.92%). The seeds of H. auriculata were extracted
with 80% ethanol:water in cold extraction process
(yield¼1.15%). The dried whole plant of L. speciosa
was first defatted with petroleum ether and then extracted
with chloroform and the yield was 7.1%. The roots of
H. indicus Linn (yield¼8.9%), the stem barks
of P. longifolia (Sonn.) (yield¼6.87%), the seed of
V. anthelmintica (yield¼15.24) and the stem barks of
A. polystachya Wall & Parker were extracted with 80%
ethanol:water in cold extraction process. The extraction
of A. polystachya resulted in two extracts, an oily phase and
a solid mass, with a yield of 2.54% and 8.91%, respectively.
The roots of M. oleifera Lamk. were extracted with
absolute ethanol in a cold extraction process. This crude
extract (yield¼14.54%) was further partitioned with
n-hexane (yield¼7.39%), chloroform (yield¼5.94%),
methanol (yield¼9.46%) and water (yield¼9.48%). The
dried fruits of E. officinalis were extracted with absolute
ethanol (yield¼9.33%). This ethanolic extract was
defatted with petroleum ether and the defatted extract
was successively fractionated with different solvent systems
on the basis of polarity. The solvents were 100%
dichloromethane, 25% ethylacetate-dichloromethane,
50% ethylacetatedichloromethane, 75% ethylacetate-
dichloromethane, 100% ethylacetate, butanol and acetone
and the remaining aqueous portions were separated. The
dried whole plant of R. maritimus was first extracted with
methanol (yield¼11.21%), then defatted with petroleum
ether (yield¼9.87) and successively extracted with chloro-
form, ethylacetate and methanol (yield¼8.7). The whole
plant of A. mexicana were extracted with methanol
(yields¼1.25%).
Cell Lines, Culture Conditions and Assays of in vitro
Antiproliferative Activity
Human erythroleukemia K562 (48), B lymphoid Raji (49)
and T lymphoid Jurkat (50) cells were maintained in
RPMI 1640 (Flow Laboratories, Irvine, UK) at 37 Ci na
humidified 5% CO2 atmosphere, supplemented with 10%
fetal bovine serum (FBS; CELBIO, Milano, Italy), 100
units/ml penicillin and 100mg/ml streptomycin (Aldrich,
St.Louis, MA, USA). For analyzing the effects on in vitro
cell growth, cells were seeded at the initial cell
concentration of 30000 cells/ml, cultured in the absence
or presence of plant extracts and the cell number/ml
determined using a model ZBI Coulter Counter (Coulter
Electronics, Hialeah, FL, USA) after 2, 3, 4, 5 days of
cell culture. The IC50 values (i.e. the concentrations of
extracts leading to 50% inhibition of cell growth, when
treated cells are compared with untreated, control
cultures) were determined in order to compare the
activities of the different extracts. IC50 was determined
usually after 4 days, when untreated cells are in the log
phase of cell growth.
Electrophoretic Mobility Shift Assay (EMSA)
Electrophoretic mobility shift assay was performed by
using double stranded
32P-labeled oligonucleotides as
target DNA. Binding reactions were set up as
described elsewhere in binding buffer (10% glycerol,
0.05% NP-40, 10mM Tris-HCl pH 7.5, 50mM NaCl,
0.5mM DTT, 10mM MgCl2), in the presence of
poly(dI:dC).poly(dI:dC) (Pharmacia, Uppsala, Sweden),
2–5mg of crude nuclear extracts and 0.25ng of labeled
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30min binding at room temperature samples were
electrophoresed at constant voltage (200V for 1h)
through a low ionic strength (0.25 TBE buffer)
(1 TBE¼0.089M Tris-borate, 0.002M EDTA) on 6%
polyacrylamide gels until tracking dye (bromophenol
blue) reached the end of a 16cm slab. Gels were dried
and exposed for autoradiography with intensifying
screens at  80 C. In these experiments, DNA/
protein complexes migrate through the gel with slower
efficiency. In studies on the inhibitors of protein/DNA
interactions, addition of the reagents was as follows:
(i) poly(dI:dC).poly(dI:dC); (ii) labeled oligonucleotides
mimicking the binding sites for TFs to be modulated;
(iii) plant extracts; (iv) binding buffer; (v) nuclear factors.
The nucleotide sequences of double-stranded target DNA
utilized in these experiments were 50-CGC TGG GGA
CTT TCC ACG G-30 (sense strand, NF-kB), 50-CGC
TTG ATG AGT CAG CCG GAA-30 (AP-1), 50-CAC
TTG ATA ACA GAA AGT GAT AAC TCT-30
(GATA-1), 50-CTG ATT TCC CCG AAA TGA
CGG -30 (STAT-3) and 50-TTG AAT GAC GTC AAG
GCC-30 (CREB). The synthetic oligonucleotides utilized
in this study were purchased from Sigma Genosys (Sigma
Genosys, Cambs, UK). For quantitative determinations,
the bands corresponding to protein-DNA complexes were
analyzed using the BIO-RAD Gel Doc 2000 (Bio-Rad
Laboratories). The values obtained in the reactions
performed in the presence of plant extracts were
compared with control untreated reactions.
Results
Differential Inhibitory Effects of Extracts of Bangladeshi
Medicinal Plants on in vitro Proliferation of Human
Tumor Cell Lines
In order to obtain preliminary information on the
biological properties of the employed extracts, their effects
on cell growth were examined. The extracts isolated from
E. officinalis, A. marmelos, M. oleifera, T. arjuna,
V. anthelmintica, O. indicum, S. asoka, R. maritimus,
L. speciosa, Red sandal, C. reflexa, A. mexicana, H. indicus,
P. longifolia, C. sophera, P. foetida, H. auriculata,
O. sanctum and A. polystachya were first tested as potential
inhibitors of in vitro proliferation of human erythroleu-
kemic K562 cells. Figure 1 shows some representative
results on the effects of increasing amounts of plant
extracts on proliferation of K562 cells. The complete set
of results is shown in Table 1, which summarizes the data
derived from four independent experiments. The highest
antiproliferative activity was found using extracts from
E. officinalis (IC50¼0.75 0.04 and 0.51 0.08mg/ml
from unfractionated and n-butanolic extracts,
respectively), O. indicum (IC50¼3.77 0.32mg/ml),
Figure 1. Effects of extracts from medicinal plants on K562 cell
proliferation. K562 cells were seeded at the initial cell concentration of
30000 cells/ml and then cultured for 7 days in the presence of the
indicated amounts of n-butanol extracts from E. officinalis (black
circles, solid line), M. oleifera (black squares, solid line), tetrachlor-
omethane fraction of A. marmelos (white circles, solid line), T. arjuna
(white squares), O. indicum (black triangles), H. indicus (white triangles),
P. foetida (black circles, dotted line), H. auriculata (white circles, dotted
line) and C. sophera (black squares, dotted line).
Table 1. Antiproliferative effects of different extracts derived from
Bangladeshi medicinal plants on erythroleukemic K562 cells
Medicinal plant IC50 (mg/ml)
E. officinalis (unfractionated extract) 0.75 0.04
E. officinalis (n-butanolic extract) 0.51 0.08
A. marmelos (ethyl acetate fraction) 135.50 17.54
A. marmelos (petroleum ether fraction) 8.30 0.99
A. marmelos (tetrachloromethyl fraction) 30.25 2.76
M. oleifera 6.88 6.05
T. arjuna 4.45 0.50
V. anthelmintica 66.84 1.64
O. indicum 3.77 0.32
S. asoka 48.50 12.02
R. maritimus (acqueous fraction) 39.94 4.43
R. maritimus (methanolic fraction) 303.80 118.44
L. speciosa 46.00 6.01
Red sandal 36.94 5.88
C. reflexa 115.67 47.14
A. mexicana 59.56 6.65
H. indicus 626.76 93.99
P. longifolia 212.63 20.04
C. sophera 483.88 134.42
P. foetida 799.54 44.49
H. auricolata 523.77 23.89
O. sanctum 67.01 2.24
A. polystachia (solid fraction) 41.06 0.02
A. polystachia (oil fraction) 91.50 17.76
The reported data represent the concentrations (average SD of four
independent experiments) of plant extracts leading to a 50% inhibition
of cell growth.
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(IC50¼8.30 0.99mg/ml, petroleum ether fraction) and
M. oleifera (IC50¼16.88 6.05mg/ml). The other
tested plant extracts displayed lower antiproliferative
activity (Table 1).
The most active plant extracts on K562 cells were also
tested on B lymphoid Raji and T lymphoid Jurkat human
tumor cell lines. Figure 2 shows the effects on cell growth
of Raji and Jurkat cells treated with increasing amounts
of the extracts. Table 2 shows the IC50 values obtained
for each cell line. The obtained data indicate that these
plant extracts, despite some differences, inhibit the in
vitro proliferation of all analyzed human tumor cell lines.
These results confirm and further extend the list of
analyzed compounds previously published on the anti-
proliferative activity of E. officinalis (35), A. marmelos
(37), V. anthelmintica, O. indicum, A. mexicana (39).
Identification of Plant Extracts Exhibiting High Levels
of Inhibitory Activity on Protein-DNA Interactions
To determine whether inhibitory activities against
TFs/DNA interactions are present in extracts from
medicinal plants, the same plant extracts that were tested
for antiproliferative activity were assayed for their ability in
inhibiting the interactions between nuclear factors isolated
from the human leukemic K562 cells and double stranded
target oligonucleotides that mimic the binding sites of the
NF-kB, AP-1, GATA-1, STAT-3 and CREB TFs.
Representative results are shown in Figs. 3–6 and
summarized in Table 3. The electrophoretic mobility shift
assay was performed using [g-
32P] 50-end-labeled oligo-
nucleotides. The 50-labeled oligonucleotides were incu-
bated with plant extracts for 15min and then nuclear
extracts were added. After 15min binding at room
temperature, the samples were electrophoresed. The gels
were dried and subjected to standard autoradiographic
procedures.
As far as the inhibitory effects on NF-kB/DNA
interactions (Figs. 3 and 4), the results show that high
activity was exhibited by E. officinalis, ethyl acetate and
petroleum ether fractions of A. marmelos, M. oleifera,
V. anthelmintica, aqueous and methanolic fractions
of R. maritimus, L. speciosa, H. indicus, P. longifolia,
T. arjuna, S. asoka and solid and oil fractions of
A. polystachya. On the contrary, high concentrations
of extracts from O. indicum, Red sandal, C. reflexa,
A. mexicana, C. sophera, P. foetida, H. auriculata and
O. sanctum were unable to inhibit NF-kB/DNA interac-
tions. In conclusion, when Figs 3 and 4 and Table 3 are
considered together, the highest effects against NF-kB
activity were displayed by T. arjuna, S. asoka and
A. polystachya.
Terminalia arjuna, S. asoka and A. polystachya (solid
fraction) are the most effective extracts inhibiting also
AP-1/DNA interactions (Fig. 5A). Extracts showing a
moderate inhibitory activity instead were derived from
M. oleifera and aqueous fraction of R. maritimus.
A lower activity was characterized by E. officinalis,
A. marmelos, O. indicum, L. speciosa, H. indicus and oil
fraction of A. polystachya. The other extracts were
inactive.
Figure 2. Inhibitory effects of extracts from E. officinalis (unfractio-
nated extracts, black circles; n-butanolic extracts, white triangles),
O. indicum (black triangles), T. arjuna (white squares), M. oleifera
(black squares) and A. marmelos (petroleum ether fraction, white
circles) on proliferation of Raji (panel A) and Jurkat (panel B) cell lines.
Cells were seeded at the initial cell concentration of 30000 cells/ml and
then cultured for 7 days in the presence of the indicated amounts of
extracts.
Table 2. Antiproliferative activity (IC50, mg/ml) of extracts of
E. officinalis, A. marmelos, M. oleifera, T. arjuna and O. indicum on
Raji and Jurkat cell lines
Medicinal plant Raji cells Jurkat cells
E. officinalis (unfractionated extract) 24.43 9.4 33.28 6.2
E. officinalis (n-butanolic extract) 17.93 8.0 10.77 6.1
A. marmelos (petroleum ether fraction) 0.30 0.1 35.25 3.8
M. oleifera 1.82 0.2 18.00 2.0
T. arjuna 63.00 5.0 4500.00
O. indicum 23.20 9.6 4.11 0.1
The reported data represent the concentrations (average SD of four
independent experiments) of plant extracts leading to a 50% inhibition
of cell growth.
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inhibition of interaction between GATA-1 and DNA. As
far as inhibition of GATA-1/DNA interaction, petroleum
ether fraction of A. marmelos, R. maritimus aqueous
fraction, S. asoka, A. polystachya solid fraction,
M. oleifera, V. anthelmintica and L. speciosa extracts
were efficient (Fig. 5B). Emblica officinalis extracts
showed a intermediate activity, whereas 100mg/binding
reaction of extracts from A. marmelos, R. maritimus
methanolic fraction, Red sandal, C. reflexa, A. mexicana,
H. indicus, C. sophera, P. foetida, H. auriculata,
O. sanctum and A. polystachya oil fraction were still
unable to inhibit GATA-1/DNA interactions.
As far as STAT-3/DNA interaction, in addition to
T. arjuna extracts the aqueous fraction of R. maritimus,
S. asoka and solid fraction of A. polystachya extracts
were also inhibitory (Fig. 6A), while only 75mg/binding
reaction of ethyl acetate fraction of A. marmelos and
O. sanctum extracts displayed inhibitory activity. The
remaining extracts were not capable of any activity.
Finally, regarding the CREB/DNA interaction studies,
Table 3 and the related Fig. 6B show that, in addition to
T. arjuna extracts, only those from S. asoka and
E. officinalis possess an intermediate activity, whereas
the other medicinal plant extracts are completely inactive.
Figure 4. Extracts from medicinal plants differentially inhibit molecular
interactions between NF-kB and target DNA sequences. The effects
on NF-kB/DNA interactions of the indicated amounts of extracts from
A. marmelos, P. longifolia, L. speciosa, V. anthelmintica, H. indicus and
A. mexicana are reported. For description of the technical detail, see
legend to Fig. 3.
*¼free probe; arrows¼NF-kB/DNA complexes.
Figure 3. Extracts from medicinal plants differentially inhibit molecular
interactions between NF-kB and target DNA sequences. The effects
on NF-kB/DNA interactions of the indicated amounts of extracts
(mg/binding reactions) from T. arjuna, R. maritimus (aqueous extract),
S. asoka, E. officinalis and A. polystachia (solid and oil fractions) were
studied by EMSA. The addition of the reagents in the 20ml binding
reactions was as follows: (i) poly(dI:dC).poly(dI:dC); (ii) labeled
oligonucleotides mimicking the binding sites for TFs to be assayed;
(iii) plant extracts; (iv) binding buffer; (v) nuclear factors. After 30min
binding, samples were electrophoresed on 6% polyacrylamide gels, that




Inhibition of DNA-protein interactions could be a very
promising strategy for the development of antitumor and
antiviral therapeutic agents, as well as for the interven-
tion in other different human pathologies related to
inflammation, such as rheumatoid arthritis, chronic
asthma and inflammatory bowel diseases (22–26).
DNA-binding drugs are extremely relevant and are the
object of numerous research articles. Consistent results by
our team and other research groups demonstrated that
DNA-binding drugs inhibit the molecular interactions
between DNA and TFs, leading to alteration of
transcription (51–56). To analyze the possible interactions
between TFs and the specific DNA elements we
employed the EMSA for all preliminary experiments. In
this context, several plant extracts were described able to
inhibit DNA-protein interactions, and they may be a
possible source of lead compounds that can alter gene
expression.
The aim of this study was to screen several plant
extracts for their ability to inhibit molecular interactions
between DNA and TFs involved in the process of
inflammation, including NF-kB, AP-1, STATs, CREB
and GATA-1. Natural products derived from medicinal
plants might play an interesting role for the identification
of novel drugs for treating several diseases and they
represent an important alternative source (57) for
molecules inhibiting NF-kB activity.
For example, utilizing macrophages transfected with a
vector coding for the luciferase reporter gene under the
control of NF-kB cis-acting elements, investigators demon-
strated that LPS (LipoPolySaccharide)-stimulated lucifer-
ase activity was affected by adding of extracts from the
medicinal plant Glossogyne tenuifolia, utilized in Chinese
medicine as a traditional antipyretic herb (58). Accordingly
G. tenuifolia attenuates inflammatory mediator synthesis of
activated macrophages through an NF-kB-dependent
pathway. Moreover, the identified oleanolic acid and
luteolin-7-glucoside, present in the extracts derived from
this medicinal plant, inhibited LPS-stimulated inflamma-
tory mediator production and NF-kB activation (58).
A second example is related to recent studies demon-
strating that garcinol, a polyisoprenylated benzophenone
derived from another medicinal plant, Garcinia indica,
exhibits antioxidative effects in vitro. Liao et al. (59)
Figure 5. Extracts from medicinal plants inhibiting molecular interactions between AP-1 (A) and GATA-1 (B) TFs and target DNA sequences. The
effects of the indicated amounts of extracts from T. arjuna, R. maritimus, S. asoka and A. polystachya were studied on AP-1/DNA (A) and GATA-1/
DNA (B) interactions. For description of the technical detail, see legend to Figure 3.
*¼free probe; arrows¼protein/DNA complexes.
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assays (EMSA) that garcinol strongly blocks the activa-
tion of eukaryotic TF NF-kB-induced by LPS. Moreover,
for instance, transient transfection experiments showed
that garcinol inhibited the NF-kB-dependent transcrip-
tional activity.
The main conclusion of the present article is that
inhibitory activity against TFs is displayed by several
plant extracts, as shown in Table 3, in which the IC50
values (concentration leading to 50% inhibition of TFs/
DNA interactions) of the electrophoretic mobility shift
assays are summarized. The data suggest that P. long-
ifolia represents an extract displaying interesting selectiv-
ity in inhibiting only the NF-kB/DNA interaction,
whereas for example T. arjuna demonstrated a very
high activity in all TFs/DNA binding experiments. Both
extracts derived from E. officinalis interfered preferen-
tially with NF-kB/DNA interaction with lower selectivity
than P. longifolia, while only one fraction of A. marmelos
(pet. ether extract) was selective for GATA-1/DNA
interaction. Hemidesmus indicus also appears to be an
interesting selective extract, since it inhibits NF-kB/DNA
interaction at 12mg/ml, while it is active on the other
TF/DNA interactions only when added at 50mg/ml or
higher concentrations.
Both A. polystachya fractions proved a high, but not
selective, activity particularly on the inhibition of NF-kB/
DNA interactions. Moringa oleifera and L. speciosa
extracts were active on NF-kB, AP-1 and GATA-1
and inactive on other TFs. Vernonia anthelmintica
demonstrated activity with NF-kB and GATA-1 only.
Saraca asoka inhibited all TFs/DNA interactions even
if at different concentrations. The aqueous fraction of
R. maritimus was more active in inhibiting NF-kB, AP-1,
GATA-1 and STAT-3 interactions than the methanolic
extract, which interfered at intermediate concentrations
with NF-kB/DNA interaction only. Ocimum sanctum was
the only extract that selectively inhibited the STAT-3/
DNA interaction. Finally, the remaining medicinal plant
extracts were ineffective on all protein/DNA interactions.
These data support the concept that medicinal plant
extracts represent a potential source of compounds
exhibiting the ability to suppress the molecular interactions
between TFs and target DNA sequences. Further experi-
ments [Gas Chromatography/Mass Spectrometry (GC/
MS), High-Performance Liquid Chromatography/Mass
Figure 6. Extracts from medicinal plants inhibiting molecular interactions between STAT-3 (A) and CREB (B) and target DNA sequences. The
effects of the indicated amounts of extracts from T. arjuna, R. maritimus, S. asoka and A. polystachya were studied on STAT-3/DNA (A) and CREB/
DNA (B) interactions. For description of the technical detail, see legend to Fig. 3.
*¼free probe; arrows¼protein/DNA complexes.
eCAM 2008;5(3) 309Spectrometry (LC/MS)] should be performed to identify
pure compounds exhibiting these activities. However, it
should be pointed out that several compounds have already
been described in plant extracts analyzed in the present
article. For instance, three thiocarbamate (TC)- and
isothiocyanate (ITC)-related compounds have been iso-
lated from the leaves of M. oleifera (60). In addition, the
oleanane triterpenes arjunic acid, arjungenin and their
glucosides, arjunetin and arjunglucoside II, were isolated
from the bark of T. arjuna (61). Several flavonoids
including 20,3,4,40-tetrahydroxychalcone, 5,6,7,40-tetrahy-
droxyflavone and butin, were separated from the seeds of
V. anthelmintica (62). The leaves of L. speciosa afforded a
new natural product, 31-norlargerenol acetate, along with
known compounds 24-methylenecycloartanol acetate, its
31-nor analog, largerenol acetate, tinotufolins C and D,
lutein, phytol, sitosterol and sitosterol acetate (63).
Pyrogallol was identified in extracts from E. officinalis (35).
Therefore, EMSA analysis of the activity of the compounds
already demonstrated to be present in the plant extracts
exhibiting inhibitory activity on TF/DNA interactions is
expected to help in identifying the molecules responsible for
the activity of the plant extracts.
As far as the possible relationships between effects on
cell growth and effects on protein-DNA interactions,
when data from Tables 1–3 are compared, evidently
some extracts, including for example O. indicus,
E. officinalis, T. arjuna and A. marmelos (petroleum
ether fraction), inhibit TFs/DNA interactions and are
also highly effective in inhibiting cell proliferation. This is
expected, considering the relevant involvement of TFs on
cell cycle progression. On the contrary, other extracts,
even inhibiting protein/DNA interactions, do not display
antiproliferative activity.
Therefore, our study suggests that medicinal plant
extracts exhibiting inhibitory activity on cell proliferation
Table 3. Inhibitory effects of plant extracts on the interactions between nuclear factors and double stranded synthetic oligonucleotides mimicking the
binding sites of the NF-kB, AP-1, GATA-1, STAT-3 and CREB trascription factors
Medicinal plant NF-kB* AP-1* GATA-1* STAT-3* CREB*
E. officinalis
unfractionated extract 12.5 25 50 100 50
n-butanolic extract 12.5 25 50 100 100
A. marmelos
ethyl acetate fraction 25 100 4400 75 4100
petroleum ether fraction 50 50 6.25 4100 4100
CCl4 fraction 4100 4400 4400 4100 4100
M. oleifera 25 12.5 25 4100 4100
T. arjuna 3.12 3.12 3.12 1.50 6.25
V. anthelmintica 12.5 100 25 100 4100
O. indicum 4100 50 100 4100 4100
S. asoka 1.5 6.25 12.5 12.5 12.5
R. maritimus
acqueous fraction 12.5 12.5 12.5 6.25 4100
methanolic fraction 25 100 400 4100 4100
L. speciosa 25 50 25 4100 4100
Red sandal 100 400 400 4100 4100
C. reflexa 4100 400 400 4100 4100
A. mexicana 100 4400 4400 100 4100
H. indicus 12.5 50 4100 4100 4100
P. longifolia 12.5 4100 4100 4100 4100
C. sophera 100 4100 4100 4100 4100
P. foetida 4100 100 100 4100 4100
H. auricolata 4100 4100 4100 4100 4100
O. sanctum 4100 4100 4100 75 4100
A. polystachya
solid fraction 0.75 6.25 12.5 12.5 100
oil fraction 6.25 50 4100 50 4100
*Concentrations are expressed in mg/binding reaction (20ml). The data reported represent the concentrations of plant extracts leading to a 50%
inhibition of protein/DNA interactions.
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while extracts displaying inhibition of TFs/DNA interac-
tions without effects on cell growth kinetics might be
employed to control TFs-dependent gene expression
without cytotoxic effects, including the case of inflam-
matory processes involved in relevant human pathologies,
such as rheumatoid arthritis and cystic fibrosis.
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